Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Nanoparticles Targeting Receptors on Breast Cancer for Efficient Delivery of Chemotherapeutics
Sulltana Jahan, Md. Emranul Karim, Ezharul Hoque Chowdhury
Biomedicines (2021) Vol. 9, Iss. 2, pp. 114-114
Open Access | Times Cited: 63

Showing 1-25 of 63 citing articles:

Enhanced permeability and retention effect: A key facilitator for solid tumor targeting by nanoparticles
Vinod Ravasaheb Shinde, Neeraja Revi, Sivasubramanian Murugappan, et al.
Photodiagnosis and Photodynamic Therapy (2022) Vol. 39, pp. 102915-102915
Closed Access | Times Cited: 102
Nanotechnology in healthcare, and its safety and environmental risks
Xiaohan Ma, Yaxin Tian, Yang Ren, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 27
Natural compounds-based nanomedicines for cancer treatment: Future directions and challenges
Tatiana Andreani, Ruoyu Cheng, Khalil Elbadri, et al.
Drug Delivery and Translational Research (2024) Vol. 14, Iss. 10, pp. 2845-2916
Open Access | Times Cited: 20
Mitochondria‐targeted nanoparticles in treatment of neurodegenerative diseases
Yue Zhang, Han Yang, Daohe Wei, et al.
Exploration (2021) Vol. 1, Iss. 3
Open Access | Times Cited: 96
Gadolinium doped red-emissive carbon dots as targeted theranostic agents for fluorescence and MR imaging guided cancer phototherapy
Min Jiao, Yuxin Wang, Wenjun Wang, et al.
Chemical Engineering Journal (2022) Vol. 440, pp. 135965-135965
Open Access | Times Cited: 64
Evaluation of Anticancer Potential of Biogenic Copper Oxide Nanoparticles (CuO NPs) against Breast Cancer
Torki A. Zughaibi, Ahmed A. Mirza, Mohd Suhail, et al.
Journal of Nanomaterials (2022) Vol. 2022, Iss. 1
Open Access | Times Cited: 59
Extracellular vesicles for improved tumor accumulation and penetration
Nana Bie, Tuying Yong, Zhaohan Wei, et al.
Advanced Drug Delivery Reviews (2022) Vol. 188, pp. 114450-114450
Closed Access | Times Cited: 41
Unraveling the role of miRNAs in the diagnosis, progression, and therapeutic intervention of Alzheimer’s disease
Nourhan M. Abdelmaksoud, Al-Aliaa M. Sallam, Ahmed I. Abulsoud, et al.
Pathology - Research and Practice (2023) Vol. 253, pp. 155007-155007
Closed Access | Times Cited: 23
Graphene-based nanomaterials for breast cancer treatment: promising therapeutic strategies
Guangman Cui, Junrong Wu, Jia-Yin Lin, et al.
Journal of Nanobiotechnology (2021) Vol. 19, Iss. 1
Open Access | Times Cited: 55
Implantable smart hyperthermia nanofibers for cancer therapy: Challenges and opportunities
Amir Valizadeh, Samira Asghari, Saleheh Abbaspoor, et al.
Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology (2023) Vol. 15, Iss. 6
Closed Access | Times Cited: 19
Development and Characterization of Folic Acid-Conjugated Amodiaquine-Loaded Nanoparticles–Efficacy in Cancer Treatment
Vineela Parvathaneni, Snehal K. Shukla, Vivek Gupta
Pharmaceutics (2023) Vol. 15, Iss. 3, pp. 1001-1001
Open Access | Times Cited: 17
Nature meets technology: Harnessing nanotechnology to unleash the power of phytochemicals
Divya Teli, Riyansi Satasia, Vishwa Patel, et al.
Deleted Journal (2024) Vol. 5, Iss. 2, pp. 200139-200139
Open Access | Times Cited: 7
EGFR Targeting of Liposomal Doxorubicin Improves Recognition and Suppression of Non-Small Cell Lung Cancer
Ernest Moles, David Chang, Friederike M. Mansfeld, et al.
International Journal of Nanomedicine (2024) Vol. Volume 19, pp. 3623-3639
Open Access | Times Cited: 7
Scope and challenges of nanoparticle-based mRNA delivery in cancer treatment
Md. Emranul Karim, Sheikh Tanzina Haque, H.A. Al-Busaidi, et al.
Archives of Pharmacal Research (2022) Vol. 45, Iss. 12, pp. 865-893
Open Access | Times Cited: 27
Phytosterol-Loaded Surface-Tailored Bioactive-Polymer Nanoparticles for Cancer Treatment: Optimization, In Vitro Cell Viability, Antioxidant Activity, and Stability Studies
Shahid Karim, Md Habban Akhter, Abdulhadi S. Burzangi, et al.
Gels (2022) Vol. 8, Iss. 4, pp. 219-219
Open Access | Times Cited: 23
CD44-Targeted Lipid Polymer Hybrid Nanoparticles Enhance Anti-Breast Cancer Effect of Cordyceps militaris Extracts
Jiraphong Suksiriworapong, Nutthachai Pongprasert, Somnuk Bunsupa, et al.
Pharmaceutics (2023) Vol. 15, Iss. 6, pp. 1771-1771
Open Access | Times Cited: 15
In-vivo studies of targeted and localized cancer drug release from microporous poly-di-methyl-siloxane (PDMS) devices for the treatment of triple negative breast cancer
S. C. Eluu, John D. Obayemi, Ali A. Salifu, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 5
Foliate-Targeting Quantum Dots-β-Cyclodextrin Nanocarrier for Efficient Delivery of Unsymmetrical Bisacridines to Lung and Prostate Cancer Cells
Joanna Pilch, Patrycja Kowalik, Agata Kowalczyk, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 3, pp. 1261-1261
Open Access | Times Cited: 22
Nanoparticulate drugs and vaccines: Breakthroughs and bottlenecks of repurposing in breast cancer
Popat Kumbhar, Kapil Kole, Varsha Khadake, et al.
Journal of Controlled Release (2022) Vol. 349, pp. 812-830
Closed Access | Times Cited: 22
Exploring Contemporary Breakthroughs in Utilizing Vesicular Nanocarriers for Breast Cancer Therapy
Nalla Usha Kumari, Ekta Pardhi, Padakanti Sandeep Chary, et al.
Therapeutic Delivery (2024) Vol. 15, Iss. 4, pp. 279-303
Closed Access | Times Cited: 4
Folic acid modified precision nanocarriers: charting new frontiers in breast cancer management beyond conventional therapies
Nida Nehal, Aashish Rohilla, Ali Sartaj, et al.
Journal of drug targeting (2024) Vol. 32, Iss. 8, pp. 855-873
Closed Access | Times Cited: 4
Somatostatin receptor-targeted polymeric nanoplatform for efficient CRISPR/Cas9 gene editing to enhance synergistic hepatocellular carcinoma therapy
Suqin Zhang, Meng Li, Jingyi Zeng, et al.
Journal of Nanobiotechnology (2025) Vol. 23, Iss. 1
Open Access
Advances in nanotechnology for targeting cancer-associated fibroblasts: A review of multi-strategy drug delivery and preclinical insights
Zhongsong Zhang, Yujie Tang, Dan Luo, et al.
APL Bioengineering (2025) Vol. 9, Iss. 1
Open Access
Targeted delivery of neratinib/xanthan gum-capped calcium carbonate nanoparticles induces apoptosis through PI3K/AKT pathway in breast cancer mice model
Yilin Wu, Yanxi Liu, Yawen Zhang, et al.
International Journal of Biological Macromolecules (2025), pp. 142963-142963
Closed Access
Paclitaxel in colon cancer management: from conventional chemotherapy to advanced nanocarrier delivery systems
Komal Komal, Bibhu Prasad Nanda, L. Singh, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2024) Vol. 397, Iss. 12, pp. 9449-9474
Closed Access | Times Cited: 3
Page 1 - Next Page

Scroll to top